{"transactions":[{"id":3510738,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":154410,"kind":"person","name":"Javid Parker K","position":1,"cik":"0001748560","reported_name":"Javid Parker K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Restricted Stock Unit","published_at":"2019-05-28T21:42:50.000Z","date":"2019-05-25","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted on May 25, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 25, 2019."}],"balance_after":0,"derivative":{"exercise_date":"2019-05-25","expiration_date":"2019-05-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-19-007268","document":"wf-form4_155907975494366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019007268/wf-form4_155907975494366.xml","form_type":"4"}},{"id":3510737,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":154410,"kind":"person","name":"Javid Parker K","position":1,"cik":"0001748560","reported_name":"Javid Parker K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common Stock","published_at":"2019-05-28T21:42:50.000Z","date":"2019-05-25","kind":"tax_withholding","acquired":false,"shares":3528,"price":9.42,"value":33233.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":6472,"source":{"system":"sec-edgar","filing":"0001628280-19-007268","document":"wf-form4_155907975494366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019007268/wf-form4_155907975494366.xml","form_type":"4"}},{"id":3510736,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":154410,"kind":"person","name":"Javid Parker K","position":1,"cik":"0001748560","reported_name":"Javid Parker K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common Stock","published_at":"2019-05-28T21:42:50.000Z","date":"2019-05-25","kind":"exercise","acquired":true,"shares":10000,"price":9.42,"value":94200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001628280-19-007268","document":"wf-form4_155907975494366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019007268/wf-form4_155907975494366.xml","form_type":"4"}},{"id":3666440,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":154410,"kind":"person","name":"Javid Parker K","position":1,"cik":"0001748560","reported_name":"Javid Parker K","relationship":{"officer":true,"officer_title":"Vice President"}}],"security":"Right to Buy Restricted Stock Unit (RSU)","published_at":"2019-02-12T01:45:34.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":3631,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units will be automatically settled in shares of common stock subject to achievement of the performance goals set forth in the Company's LTIP for 2021."}],"balance_after":3631,"derivative":{"expiration_date":"2021-07-25","underlying":"Common Stock","underlying_shares":3631},"source":{"system":"sec-edgar","filing":"0001437749-19-002267","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000143774919002267/rdgdoc.xml","form_type":"4/A","original_submission_date":"2019-01-30"}},{"id":3682015,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":154410,"kind":"person","name":"Javid Parker K","position":1,"cik":"0001748560","reported_name":"Javid Parker K","relationship":{"officer":true,"officer_title":"Vice President"}}],"security":"Right to Buy Restricted Stock Unit (RSU)","published_at":"2019-01-31T19:32:12.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":3631,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units will be automatically settled in shares of common stock subject to achievement of the performance goals set forth in the Company's LTIP for 2021."}],"balance_after":3631,"derivative":{"expiration_date":"2022-01-30","underlying":"Common Stock","underlying_shares":3631},"source":{"system":"sec-edgar","filing":"0001437749-19-001586","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000143774919001586/rdgdoc.xml","form_type":"4"}}]}